By Representatives Higgins of Leominster and Scarsdale of Pepperell, a petition (accompanied by bill, House, No. 2445) of Natalie M. Higgins, Margaret R. Scarsdale and others relative to essential services in hospitals. Public Health.
This bill allows pharmacists in Massachusetts to test for, screen, and initiate treatment for specific health conditions - including Influenza, Streptococcal infections, COVID-19, and HIV (including PrEP/PEP) - under a statewide protocol established by the Board of Pharmacy. It directly affects pharmacists (expanding their clinical role) and patients seeking accessible testing and initial treatment for these conditions. Key provisions require pharmacists to follow the protocol, delegate administrative tasks to technicians under supervision, and refer high-risk patients for hospital care when needed. The bill also mandates insurance companies to reimburse pharmacists for these services at standard rates for other healthcare providers, ensuring fair compensation.
This bill (SD 193) requires Medicare to annually release specific healthcare cost and utilization data to the public. It mandates the release of hospital data for the 100 most common inpatient stays and the 10 most expensive inpatient stays by payer, plus outpatient procedure data, physician payment details showing allowed amounts versus submitted charges, and drug prescription data for the 100 most common and 10 most expensive drugs. The data must be made available in raw, usable form on Medicare’s website annually, without requiring a consumer-facing tool. This directly affects Medicare (the "center" in the bill) and healthcare providers whose data is included, as they must provide the specified information. The bill focuses on making cost and service data transparent for public access, without specifying how it will be used.
HD 1587 expands eligibility for the health safety net program to cover uninsured or underinsured patients earning up to 400% of the federal poverty level (FPL), directly affecting low-to-moderate income residents who previously faced gaps in care. It establishes that patients earning between 200%-400% FPL may have a deductible, while those below 200% FPL have full coverage. The bill also mandates retroactive eligibility for 180 days prior to an application. Additionally, it creates a task force to study the Health Safety Net Trust Fund's financing, including hospital payments and reimbursements, with a report due to the legislature within one year.
This bill requires Massachusetts insurers to cover opioid use disorder treatment provided by pharmacists at rates comparable to other nonphysician health providers. It mandates coverage under group insurance (Chapter 32A), Medicaid plans (Chapter 118E), private health insurance policies (Chapter 175), and hospital service plans (Chapter 176A). Pharmacists must be reimbursed for this service if it aligns with their scope of practice and would be covered if provided by a physician or nurse practitioner. The policy directly affects patients seeking opioid treatment and pharmacists who can now deliver this care with guaranteed insurance reimbursement.
This bill requires health insurance policies (including group plans, hospital services, and health maintenance contracts) to cover medically necessary treatments for students with disabilities, as specified in their individual education plans or similar federal special education documents. It directly affects students with disabilities whose care is outlined in these plans and their families, ensuring insurers cannot deny coverage based on disability. The law mandates that all qualifying insurance policies issued or renewed after January 1, 2024, provide equal coverage for these treatments without discrimination. It applies broadly to all relevant insurance products under Massachusetts law, aligning with existing federal special education requirements.
This bill (SD 993) requires health care providers to submit cost reports on time and blocks for-profit companies from taking over non-profit hospitals. It amends reporting rules to make submission mandatory ("shall" instead of "may") and adds a requirement for the state center to define "just cause" for reporting exemptions. Crucially, it prohibits for-profit entities from obtaining licenses to operate acute-care hospitals if they acquire a non-profit hospital after April 1, 2024, through sales, mergers, or similar transactions. The bill directly affects hospitals seeking new licenses or renewals and health care providers responsible for cost reporting.
This bill requires all health insurance plans sold in Massachusetts - including state employee group plans, individual policies, and hospital service agreements - to cover biennial echocardiograms (heart screenings) and concussion analysis for children aged 5 to 18. It directly affects insurers and policyholders by mandating this specific preventive care coverage for youth. The key provision adds new requirements to multiple chapters of state law, ensuring consistent coverage across all medical insurance types in the commonwealth. The policy change focuses on making these screenings accessible without out-of-pocket costs for families.
HD 2146 requires Massachusetts' Department of Public Health to create a mandatory assessment tool within 12 months. This tool quantifies health impacts (like asthma, hospital visits, and premature death) and associated costs or savings from energy-related emissions (e.g., pollution from power plants) and energy efficiency/renewable energy benefits. It specifically analyzes effects on environmental justice communities, MassHealth, community hospitals, and state budgets. Starting 24 months after the law takes effect, all new state energy, transportation, or waste policies must explicitly factor in the tool's health cost analysis before adoption.
This bill requires all health insurance plans in Massachusetts - including those covering state employees, group plans, and individual policies - to cover the cost of specialized medical formulas (for home use, administered orally or via tube feeding) when prescribed by a doctor for specific serious conditions. It applies to policies governed by Massachusetts law, including group insurance, hospital service plans, and medical service agreements. Coverage is limited to formulas proven effective for conditions like inherited metabolic disorders, Crohn's disease, or severe food allergies, as documented by a physician's written order stating medical necessity. The bill explicitly distinguishes these medically required formulas from general nutritional supplements taken without a medical need.
